Pancytopenia with Low Hematocrit and Elevated RDW: Evaluation and Management
This constellation of findings—pancytopenia (low absolute counts of all white cell lines) with low hematocrit and elevated RDW—strongly suggests bone marrow failure and requires urgent hematology consultation with bone marrow biopsy to evaluate for myelodysplastic syndrome (MDS), aplastic anemia, or other marrow pathology.
Key Diagnostic Considerations
The combination of cytopenias affecting multiple cell lines is a critical red flag that demands immediate attention:
Abnormalities in two or more cell lines warrant careful evaluation and likely discussion with a hematologist 1. Your patient demonstrates pancytopenia affecting all three major lineages (red cells, white cells, and platelets based on the low absolute counts across neutrophils, lymphocytes, monocytes, basophils, and eosinophils).
The elevated RDW in the context of pancytopenia helps differentiate between potential causes. While elevated RDW can occur in various conditions, when combined with pancytopenia it points toward bone marrow disorders 2.
Most Likely Differential Diagnoses
Primary Bone Marrow Failure Syndromes
Myelodysplastic syndrome (MDS) is a leading consideration given the pancytopenia pattern:
- MDS commonly presents with moderate to severe cytopenias affecting multiple cell lines 3
- The elevated RDW reflects ineffective erythropoiesis characteristic of MDS 2
- Lower-risk MDS patients frequently present with symptomatic anemia and neutropenia requiring specific management algorithms 3
Aplastic anemia must be excluded:
- Aplastic anemia presents with pancytopenia but typically shows lower mean RDW (mean 71.4 fl) compared to megaloblastic anemia (mean 87.7 fl) 2
- However, macrocytosis can occur in aplastic anemia with mean MCV of 109.7 fl 2
- The distinction between aplastic anemia and MDS requires bone marrow examination 2
Megaloblastic Anemia
- While megaloblastic anemia (B12/folate deficiency) classically shows elevated RDW (mean 87.7 fl), it typically presents with macrocytic anemia rather than true pancytopenia 2
- However, 31% of pernicious anemia patients may have normal RDW, and 35% may have normal MCV, making this diagnosis less straightforward 4
Essential Immediate Workup
Obtain the following tests urgently:
- Peripheral blood smear review to assess for dysplastic features, macro-ovalocytes, hypersegmented neutrophils, blasts, or other morphologic abnormalities 1
- Reticulocyte count to evaluate bone marrow response—a low reticulocyte count in the setting of anemia suggests inadequate erythropoietin production or bone marrow dysfunction 1
- Iron studies (serum ferritin, transferrin saturation) to assess for absolute or functional iron deficiency 1
- Vitamin B12 and folate levels to exclude nutritional deficiencies 1
- Comprehensive metabolic panel including renal function, as chronic kidney disease can cause normochromic normocytic anemia 1
Arrange urgent hematology referral for bone marrow biopsy to definitively distinguish between MDS, aplastic anemia, and other infiltrative or hypoplastic processes 3, 1.
Management Priorities Based on Severity
If Symptomatic Neutropenia is Present
- Administer broad-spectrum antibiotics immediately if fever develops 3
- Consider short-term G-CSF for severe symptomatic neutropenia 3
- Monitor closely for infectious complications given the low absolute neutrophil count 3
If Symptomatic Anemia is Present
- Provide RBC transfusions for symptomatic anemia (≥2 concentrates/month if serum EPO ≥500 U/L) 3
- Assess erythropoietin levels to guide further therapy 3
If MDS is Confirmed
The treatment algorithm depends on risk stratification:
- For lower-risk MDS with moderate cytopenias: Consider erythropoietin ± G-CSF as first-line therapy 3
- For del(5q) MDS: Lenalidomide is first-line treatment after ESA failure 3
- For higher-risk features: Consider azacitidine or clinical trial enrollment 3
- Antithymocyte globulin (ATG) may be considered if favorable features are present 3
Critical Pitfalls to Avoid
Do not attribute pancytopenia solely to nutritional deficiencies without bone marrow evaluation—while B12/folate deficiency can cause cytopenias, true pancytopenia with low absolute counts across all lineages requires marrow assessment 1
Do not delay hematology referral—abnormalities in multiple cell lines require specialist evaluation and likely bone marrow biopsy to establish diagnosis 1
RDW alone cannot reliably distinguish between causes of microcytosis or pancytopenia—it must be interpreted in the full clinical context with additional testing 5, 6
Monitor for infectious complications closely given the neutropenia and potential for rapid clinical deterioration 3